To assess the role of RIPK2 in MS, Shaw et al. used the mouse experimental autoimmune encephalomyelitis (EAE) model by immunization with myelin oligodendrocyte glycoprotein (MOG) (Shaw et al., 2011). This evidence concerns the gene RIPK2 and myeloid sarcoma.